Trading Resumes in MindBio Therapeutics
Trading resumed in MindBio Therapeutics Corp. on the CSE.
Related stories
CRA International Shares Rise 7.7% After Q3 Beat
CRA International shares rose 7.7% after the company reported a third-quarter beat.
M impact | EQUITY | Nov 05, 2026, 03:48 PM UTC
Va Tech WABAG Reports Q2 Net Profit Up 18% to ₹104 Crore
The water technology company reported consolidated net profit of ₹104 crore for the quarter ended September 2026, up 18% from ₹85 crore a year earlier. Revenue from operations was
M impact | EQUITY | Nov 05, 2026, 03:47 PM UTC
Lincoln International Reports Quarterly Results for Quarter Ended Sept. 30
LSEG's machine-generated earnings summary covers the quarter ended September 30; the supplied text contains no reported figures.
M impact | EQUITY | Nov 05, 2026, 03:47 PM UTC
Ryde Signs MOU to Explore GPU-as-a-Service Collaboration With Dimension AI
Ryde signed a memorandum of understanding to explore a GPU-as-a-Service collaboration with Dimension AI; the source supplies no further details or catalyst.
L impact | EQUITY | Nov 05, 2026, 03:47 PM UTC
South Bow to assess Prairie Connector financing after FID leverage target reached early
South Bow says it will assess financing plans for the Prairie Connector after reaching its FID leverage target sooner than expected; no further catalyst was supplied.
L impact | EQUITY | Nov 05, 2026, 03:47 PM UTC
VakıfBank reports Q3 net profit of TL 15.4 MLYR
VakıfBank reported Q3 net profit of TL 15.4 MLYR, compared with TL 11.9 MLYR in the same period last year.
M impact | EQUITY | Nov 05, 2026, 03:47 PM UTC